Table 1.
Thermogenic regulators in clinical trials.
| Name | Identifier | Condition | Phase |
|---|---|---|---|
| Propranolol | NCT03379181 | Hyperthyroidism | 4 |
| NCT01791114 | Insulin sensitivity, obesity | – | |
| Prednisone | NCT03269747 | BAT activity | 4 |
| Fluvastatin | NCT03189511 | Brown fat activity, insulin resistance | 4 |
| RZL-012 | NCT03171415 | Obesity | 2 |
| Caffeine, ephedrine | NCT02048215 | Obesity | 3 |
| β3-AR agonist | NCT01783470 | Obesity | 2 |
| Caffeine | NCT00781586 | Energy expenditure | 4 |
| Zantrex-3 | NCT02937298 | Diet-induced thermogenesis, obesity | – |
| Metobes-compound | NCT00302276 | Obesity | 2 and 3 |
| Tyrosine, green tea, caffeine | NCT02937298 | Diet-induced thermogenesis, obesity | 1 |
–Not applicable.